NOTICE OF PENDENCY OF CLASS ACTION: Please be advised that your rights may be affected by the above-captioned securities class action (the “Action”) pending in the United States District Court for the Central District of California (the “Court”), if, during the period between March 27, 2020 and February 17, 2021, inclusive (the “Settlement Class Period”), you purchased or acquired Braxia shares on the OTC stock market and were damaged thereby.

This Notice relates to a proposed Settlement of claims in a pending securities class action brought by investors alleging, among other things, that defendants Champignon Brands Inc. n/k/a Braxia Scientific Corp., (“Braxia”), Gareth Birdsall (“Birdsall”), Roger McIntyre (“McIntyre”), Stephen Brohman (“Brohman”), and Matthew Fish (“Fish”) (collectively, the “Defendants”) violated the federal securities laws by making false and misleading statements regarding Braxia.

NOTICE OF SETTLEMENT: Please also be advised that the Court-appointed Lead Plaintiff, Michael G. Quinn (“Lead Plaintiff”), on behalf of himself and the Settlement Class (as defined in ¶ 22 below), have reached a proposed settlement of the Action for $1,000,000 in cash that, if approved, will resolve all claims
in the Action (the “Settlement”).